StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Alnylam Pharmaceuticals, Inc.
NasdaqGS:ALNY
Sector
Industries
Location
Market Cap
USD 43.28 B
Share Price
USD 331.91
Avg Daily Volume
1,032,793
Change (1 day)
0.65%
Change (1 year)
33.47%
Change (YTD)
41.05%
Alnylam Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 18.29
Alnylam Pharmaceuticals, Inc. Revenue Per Share is USD 18.29 for the Trailing 12 Months (TTM) ending March 31, 2025, a 14.48% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Alnylam Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 15.97, a 71.29% change year over year.
-
Alnylam Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 9.33, a 26.28% change year over year.
-
Alnylam Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 7.39, a 50.13% change year over year.
-
Alnylam Pharmaceuticals, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 4.92, a 90.01% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.94
MRK.DE
+0.74
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.94
MRK.DE
+0.74
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%